APA (7th ed.) Citation

Denny, L., Al Abadey, A., Robichon, K., Templeton, N., Prisinzano, T. E., Kivell, B. M., & La Flamme, A. C. (2021). Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease. Clinical & Translational Immunology, 10(1), 1. https://doi.org/10.1002/cti2.1234

Chicago Style (17th ed.) Citation

Denny, Lisa, Afnan Al Abadey, Katharina Robichon, Nikki Templeton, Thomas E. Prisinzano, Bronwyn M. Kivell, and Anne C. La Flamme. "Nalfurafine Reduces Neuroinflammation and Drives Remyelination in Models of CNS Demyelinating Disease." Clinical & Translational Immunology 10, no. 1 (2021): 1. https://doi.org/10.1002/cti2.1234.

MLA (9th ed.) Citation

Denny, Lisa, et al. "Nalfurafine Reduces Neuroinflammation and Drives Remyelination in Models of CNS Demyelinating Disease." Clinical & Translational Immunology, vol. 10, no. 1, 2021, p. 1, https://doi.org/10.1002/cti2.1234.